Spinal mechanism of standard analgesics: Evaluation using mouse models of allodynia

European Journal of Pharmacology

Volumn 634, Issue 1-3, 2010, Pages 40-45

  Tsukamoto, Mina ^a   Kiso, Tetsuo ^a   Shimoshige, Yukinori ^a   Aoki, Toshiaki ^a   Matsuoka, Nobuya ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Allodynia; Analgesic; Anti nociceptive mechanism; Spinal cord

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ANALGESIC AGENT; BICUCULLINE; DIZOCILPINE; DULOXETINE; MEXILETINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID; OMEGA CONOTOXIN MVIIA; PREGABALIN; PROSTAGLANDIN E2;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SPINAL CORD; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; EVALUATION STUDY; INSTITUTE FOR CANCER RESEARCH MOUSE; INTRASPINAL DRUG ADMINISTRATION; METABOLISM; PAIN; PAIN MEASUREMENT; PROCEDURES; STANDARDS;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; PAIN; PAIN MEASUREMENT; SPINAL CORD;

EID: 77951204506     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.025     Document Type: Article

References (27)

1. Cervero F., Laird J.M. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 1996, 68:13-23.
2. 2-δ subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007, 73:137-150.
3. Copeland R., Williams J., Giannaras J., Nurnberg S., Covington M., Pinto D., Pick S., Trzaskos J. Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11202-11206.
4. 2+ channel alpha2delta ligands: novel modulators of neurotransmission. Trends Pharmacol. Sci. 2007, 28:75-82.
5. Drew G., Siddall P., Duggan A. Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 2004, 109:379-388.
6. Dworkin R., O'Connor A., Backonja M., Farrar J., Finnerup N., Jensen T., Kalso E., Loeser J., Miaskowski C., Nurmikko T., Portenoy R., Rice A., Stacey B., Treede R., Turk D., Wallace M. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
7. Finnerup N., Otto M., McQuay H., Jensen T., Sindrup S. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
8. Gil D.W., Cheevers C.V., Donello J.E. Transient allodynia pain models in mice for early assessment of analgesic activity. Br. J. Pharmacol. 2008, 153:769-774.
9. Hylden J.K.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 1980, 67:313-316.
10. Jason A., Miles D., James E. Ziconotide: an update and review. Expert Opin. Pharmacother. 2008, 9:1575-1583.
11. Kiso T., Watabiki T., Tsukamoto M., Okabe M., Kagami M., Nishimura K., Aoki T., Matsuoka N. Pharmacological characterization and gene expression profiling of an L5/L6 spinal nerve ligation model for neuropathic pain in mice. Neuroscience 2008, 153:492-500.
12. Li X., Eisenach J. Alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. JPET 2001, 299:939-944.
13. 2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic action of pregabalin. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17537-17542.
14. Meller S., Gebhart G. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52:127-136.
15. Millan M. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
16. 2 to conscious mice. Pain 1994, 57:217-223.
17. Minami T., Nishihara I., Uda R., Ito S., Hyodo M., Hayashi O. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br. J. Pharmacol. 1994, 112:735-740.
18. Minami T., Okuda-Ashitaka E., Hori Y., Sakuma S., Sugimoto T., Sakimura K., Mishina M., Ito S. Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur. J. NeuroSci. 1999, 11:1849-1856.
19. Minami T., Matsumura S., Okuda-Ashitaka E., Shimamoto K., Sakimura K., Mishima M., Mori H., Ito S. Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res. 2001, 895:178-185.
20. Onaka M., Minami T., Nishihara I., Ito S. Involvement of glutamate receptors in strychnine- and bicuculline-induced allodynia in conscious mice. Anesthesiology 1996, 84:1215-1222.
21. A and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J. Neurophysiol. 1994, 72:169-179.
22. Thor K., Kirby M., Viktrup L. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. Int. J. Clin. Pract. 2007, 61:1349-1355.
23. Thrasivoulos G., Georgios P., Ekaterrini A., Dimitrios K. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature. Eur. J. Clin. Pharmacol. 2008, 64:851-858.
24. Victoria C., Jane N., Anthony H. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats. Pain 1998, 77:289-296.
25. Whitworth T., Quick M. Upregulation of γ-amonobutyric acid transporter expression: role of alkylated γ-amonobutyric acid derivatives. Biochem. Soc. Trans. 2001, 29:736-741.
26. Williams J., Day M., Heavner J. Ziconotide: an update and review. Expert. Opin. Pharmacother. 2008, 9:1575-1583.
27. Zhang Z., Hefferan M.P., Loomis C.W. Topical bicuculline to the rat spinal cord induces highly localized allodynia that is mediated by spinal prostaglandins. Pain 2001, 92:351-361.